Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 93

    1.

    First-line antihypertensive treatment in patients with pre-diabetes: rationale, design and baseline results of the ADaPT investigation.

    Zidek W, Schrader J, Lüders S, Matthaei S, Hasslacher C, Hoyer J, Bramlage P, Sturm CD, Paar WD.

    Cardiovasc Diabetol. 2008 Jul 24;7:22.PMID: 18652658 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Influence of metabolic control on hemoglobin level in type 1 diabetic patients with nephropathy]

    Raupp D, Vogt C, Dreyhaupt J, Hasslacher C.

    Med Klin (Munich). 2008 Apr 15;103(4):185-9. German. PMID: 18484202 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Insulin requirement in patients with type 1 diabetes with reduced renal function: human insulin versus analogue insulin]

    Hasslacher C, Vogt C, Raupp D, Dreyhaupt J.

    Dtsch Med Wochenschr. 2007 Nov;132(47):2500-4. German. PMID: 18027324 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Protection of renal function in diabetics]

    Hasslacher C.

    Internist (Berl). 2007 Jul;48(7):686, 688-90, 692 passim. Review. German. PMID: 17579824 [PubMed - indexed for MEDLINE]Related articles

    5.

    External beam radiotherapy fails to prevent restenosis after iliac or femoropopliteal percutaneous transluminal angioplasty: results of a prospective randomized double-blind study.

    Fritz P, Stein U, Hasslacher C, Zierhut D, Wannenmacher M, Pritsch M.

    Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):815-21.PMID: 15183485 [PubMed - indexed for MEDLINE]Related articles

    6.

    Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function.

    Hasslacher C; Multinational Repaglinide Renal Study Group.

    Diabetes Care. 2003 Mar;26(3):886-91.PMID: 12610054 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Severe hypoglycemia in diabetics with impaired renal function]

    Hasslacher C, Wittmann W.

    Dtsch Med Wochenschr. 2003 Feb 7;128(6):253-6. German. PMID: 12571792 [PubMed - indexed for MEDLINE]Related articles

    8.

    The influence of the ACE inhibitor lisinopril on the glomerular metabolism of proteolytic enzymes in diabetic rats.

    Koenen C, Lang C, Kempe HP, Werle E, Hasslacher C.

    Acta Diabetol. 2000;37(4):185-8.PMID: 11450501 [PubMed - indexed for MEDLINE]Related articles

    9.

    Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment.

    Schumacher S, Abbasi I, Weise D, Hatorp V, Sattler K, Sieber J, Hasslacher C.

    Eur J Clin Pharmacol. 2001 May;57(2):147-52.PMID: 11417447 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Von Recklinghausen type I neurofibromatosis and neuroendocrine tumor (somatostatinoma) in a 50-year-old woman]

    Reichardt M, Rexroth W, Hasslacher C.

    Med Klin (Munich). 1998 Sep 15;93(9):550-3. Review. German. PMID: 9792022 [PubMed - indexed for MEDLINE]Related articles

    11.

    Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.

    Werle E, Fiehn W, Hasslacher C.

    Diabetes Care. 1998 Jun;21(6):994-8.PMID: 9614620 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Urinary glycosylated, free and total pyridinoline and free and total deoxypyridinoline in diabetes mellitus.

    Cloos C, Wahl P, Hasslacher C, Traber L, Kistner M, Jurkuhn K, Schmidt-Gayk H.

    Clin Endocrinol (Oxf). 1998 Mar;48(3):317-23.PMID: 9578822 [PubMed - indexed for MEDLINE]Related articles

    13.

    Levels and molecular size distribution of serum laminin in adult type I diabetic patients with and without microangiopathy.

    Werle E, Diehl E, Hasslacher C.

    Metabolism. 1998 Jan;47(1):63-9.PMID: 9440479 [PubMed - indexed for MEDLINE]Related articles

    14.

    Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria.

    Mogensen CE, Viberti GC, Peheim E, Kutter D, Hasslacher C, Hofmann W, Renner R, Bojestig M, Poulsen PL, Scott G, Thoma J, Kuefer J, Nilsson B, Gambke B, Mueller P, Steinbiss J, Willamowski KD.

    Diabetes Care. 1997 Nov;20(11):1642-6.PMID: 9353600 [PubMed - indexed for MEDLINE]Related articles

    15.

    Western blotting of NC1 type IV collagen fragments in human plasma.

    Werle E, Hao L, Hasslacher C, Fiehn W.

    Eur J Clin Invest. 1997 Jul;27(7):579-88.PMID: 9263746 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hypertension as a risk factor in non-insulin-dependent diabetes mellitus: how far should blood pressure be reduced?

    Hasslacher C.

    J Diabetes Complications. 1997 Mar-Apr;11(2):90-1. Review. No abstract available. PMID: 9101393 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Diabetic nephropathy: diagnosis and therapy]

    Hasslacher C.

    Ther Umsch. 1996 Dec;53(12):943-7. Review. German. PMID: 9036572 [PubMed - indexed for MEDLINE]Related articles

    18.

    Influence of the ACE inhibitor lisinopril on blood pressure, metabolism, and renal function parameter in hypertensive type II diabetic patients: a postmarketing surveillance study.

    Hasslacher C.

    J Diabetes Complications. 1996 May-Jun;10(3):136-8. No abstract available. PMID: 8807458 [PubMed - indexed for MEDLINE]Related articles

    19.

    Circadian variation of blood pressure in normo- and hypertensive diabetic patients with and without nephropathy.

    Kempe HP, Hasslacher C.

    Z Kardiol. 1996;85 Suppl 3:118-20.PMID: 8896313 [PubMed - indexed for MEDLINE]Related articles

    20.

    Albuminuria as an indicator of rejection in bladder-drained pancreas allografts.

    Werle E, Hasslacher C, Senninger N, Boege F, Fiehn W.

    Transplantation. 1994 Dec 27;58(12):1414-9. No abstract available. PMID: 7528952 [PubMed - indexed for MEDLINE]Related articles

    21.

    [ACE inhibitor in metabolic syndrome]

    Hasslacher C.

    Z Kardiol. 1994;83 Suppl 4:21-9. Review. German. PMID: 7856277 [PubMed - indexed for MEDLINE]Related articles

    22.

    Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients.

    Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P.

    Diabetologia. 1993 Oct;36(10):1051-6.PMID: 8243854 [PubMed - indexed for MEDLINE]Related articles

    23.

    Clinical significance of microalbuminuria and evaluation of the Micral-Test.

    Hasslacher C.

    Clin Biochem. 1993 Aug;26(4):283-7.PMID: 8242889 [PubMed - indexed for MEDLINE]Related articles

    24.

    ACE inhibitors and diabetic nephropathy: clinical and experimental findings.

    Hasslacher C, Kempe HP, Bostedt-Kiesel A.

    Clin Investig. 1993;71(5 Suppl):S20-4. Review.PMID: 8518536 [PubMed - indexed for MEDLINE]Related articles

    25.

    [ACE inhibitor effects on structure and function of the glomerular basement membrane]

    Hasslacher C, Bostedt-Kiesel A, Kempe HP.

    Klin Wochenschr. 1992;69 Suppl 29:39-44. Review. German. PMID: 1614191 [PubMed - indexed for MEDLINE]Related articles

    26.

    Effects of combined renovascular hypertension and diabetes mellitus on myocardial cells, non-vascular interstitium and capillaries: a stereological study on rat hearts.

    Fischer M, Wiest G, Tekesin I, Amann K, Mann J, Hasslacher C, Derks H, Mall G.

    Virchows Arch A Pathol Anat Histopathol. 1992;420(6):499-506.PMID: 1609510 [PubMed - indexed for MEDLINE]Related articles

    27.

    The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease.

    Zeier M, Schmid M, Nowack R, Zacharewics S, Hasslacher C, Ritz E.

    Nephrol Dial Transplant. 1992;7(6):501-6.PMID: 1320229 [PubMed - indexed for MEDLINE]Related articles

    28.

    [Albuminuria in diabetes mellitus]

    Hasslacher C.

    Wien Klin Wochenschr Suppl. 1991;189:9-12. Review. German. PMID: 1962489 [PubMed - indexed for MEDLINE]Related articles

    29.

    [Excretion of beta-N-acetylglucosaminidase in urine in type I and type II diabetic patients with and without nephropathy]

    Werle E, Bostedt A, Fiehn W, Hasslacher C.

    Wien Klin Wochenschr Suppl. 1991;189:59-62. German. PMID: 1962487 [PubMed - indexed for MEDLINE]Related articles

    30.

    [Diagnosis and therapy of diabetic nephropathy]

    Hasslacher C.

    Fortschr Med. 1990 Dec 20;108(36):694-7. Review. German. PMID: 2086427 [PubMed - indexed for MEDLINE]Related articles

    31.

    [Improved prognosis of Type I and Type II diabetics with nephropathy]

    Hasslacher C, Borgholte G, Panradl U, Wahl P.

    Med Klin (Munich). 1990 Nov 15;85(11):643-6. German. PMID: 2266913 [PubMed - indexed for MEDLINE]Related articles

    32.

    Retarding loss of renal function after onset of nephropathy.

    Ritz E, Hasslacher C.

    J Diabet Complications. 1990 Apr-Jun;4(2):82-3. No abstract available. PMID: 2145308 [PubMed - indexed for MEDLINE]Related articles

    33.

    [Hypertension and diabetes mellitus]

    Hasslacher C, Ritz E.

    Internist (Berl). 1990 Mar;31(3):180-90. Review. German. No abstract available. PMID: 2187826 [PubMed - indexed for MEDLINE]Related articles

    34.

    Diabetic nephropathy--are there differences between type I and type II?

    Ritz E, Hasslacher C, Tschöpe W.

    Miner Electrolyte Metab. 1990;16(1):69-72. Review.PMID: 2182996 [PubMed - indexed for MEDLINE]Related articles

    35.

    [Microalbuminuria screening in diabetics]

    Hasslacher C, Müller A, Panradl U, Wahl P.

    Dtsch Med Wochenschr. 1989 Jun 23;114(25):980-2. German. PMID: 2737091 [PubMed - indexed for MEDLINE]Related articles

    36.

    Impact of hypertension on prognosis in IDDM.

    Hasslacher C, Borgholte G, Ritz E, Wahl P.

    Diabete Metab. 1989;15(5 Pt 2):338-42. Review.PMID: 2693153 [PubMed - indexed for MEDLINE]Related articles

    37.

    Role of hypertension in diabetic nephropathy.

    Ritz E, Hasslacher C, Guo JZ, Mann JF.

    Contrib Nephrol. 1989;73:91-9; discussion 99-101. Review. No abstract available. PMID: 2689099 [PubMed - indexed for MEDLINE]Related articles

    38.

    Diabetic nephropathy: structural-functional relationships.

    Hasslacher C.

    Contrib Nephrol. 1989;73:24-8; discussion 28-9. Review. No abstract available. PMID: 2689095 [PubMed - indexed for MEDLINE]Related articles

    39.

    Pathogenesis of hypertension in glomerular disease.

    Ritz E, Rambausek M, Hasslacher C, Mann J.

    Am J Nephrol. 1989;9 Suppl 1:85-90. Review. No abstract available. PMID: 2646931 [PubMed - indexed for MEDLINE]Related articles

    40.

    Specific binding of angiotensin II and atrial natriuretic factor in non-nephropathic type I diabetes mellitus.

    Mann JF, Mürtz H, Sis J, Usadel KH, Hasslacher C, Ritz E.

    Nephrol Dial Transplant. 1989;4(6):530-4.PMID: 2529455 [PubMed - indexed for MEDLINE]Related articles

    41.

    Reaction patterns of the myocardial interstitium in different models of cardiac hypertrophy--stereological investigations.

    Mall G, Mattfeldt T, Rambausek M, Hasslacher C, Mann J, Ritz E.

    Gegenbaurs Morphol Jahrb. 1989;135(1):151-8.PMID: 2525497 [PubMed - indexed for MEDLINE]Related articles

    42.

    Similar risks of nephropathy in patients with type I or type II diabetes mellitus.

    Hasslacher C, Ritz E, Wahl P, Michael C.

    Nephrol Dial Transplant. 1989;4(10):859-63.PMID: 2515489 [PubMed - indexed for MEDLINE]Related articles

    43.

    [Prevention of diabetic nephropathy]

    Hasslacher C.

    Ther Umsch. 1988 Dec;45(12):888-94. Review. German. No abstract available. PMID: 3065969 [PubMed - indexed for MEDLINE]Related articles

    44.

    Rational drug treatment of the hypertensive diabetic with nephropathy.

    Ritz E, Hasslacher C, Mann J.

    J Diabet Complications. 1988 Oct-Dec;2(4):171-4. Review.PMID: 2976760 [PubMed - indexed for MEDLINE]Related articles

    45.

    Hypertension in diabetes mellitus.

    Hasslacher C, Ritz E, Tschöpe W, Gallasch G, Mann JF.

    Kidney Int Suppl. 1988 Sep;25:S133-7. No abstract available. PMID: 3184604 [PubMed - indexed for MEDLINE]Related articles

    46.

    Development of diabetic nephropathy in the rat: morphological, functional, and pathophysiological aspects.

    Hasslacher C.

    Contrib Nephrol. 1988;60:9-17. Review. No abstract available. PMID: 3278862 [PubMed - indexed for MEDLINE]Related articles

    47.

    Effect of control of diabetes mellitus on progression of renal failure.

    Hasslacher C, Ritz E.

    Kidney Int Suppl. 1987 Oct;22:S53-6. Review. No abstract available. PMID: 3323620 [PubMed - indexed for MEDLINE]Related articles

    48.

    [Diabetic nephropathy in type II diabetes: effect of metabolic control and blood pressure on its development and course]

    Hasslacher C, Wolfrum M, Stech G, Wahl P, Ritz E.

    Dtsch Med Wochenschr. 1987 Sep 18;112(38):1445-9. German. PMID: 3622292 [PubMed - indexed for MEDLINE]Related articles

    49.

    Serum concentration of laminin, and course of the disease in patients with various malignancies.

    Rochlitz C, Hasslacher C, Brocks DG, Herrmann R.

    J Clin Oncol. 1987 Sep;5(9):1424-9.PMID: 3625257 [PubMed - indexed for MEDLINE]Related articles

    50.

    Influence of hypertension on serum concentration of type IV collagen antigens in streptozotocin-diabetic and non-diabetic rats.

    Hasslacher C, Brocks D, Mann J, Mall G, Waldherr R.

    Diabetologia. 1987 May;30(5):344-7.PMID: 3609527 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...